VISCHER advised Relief regarding the Swiss legal aspects of this transaction. Relief Therapeutics Holding SA (SIX: RLF, OTCQB: RLFFD, RLFTD) has entered into a definitive agreement for the...
Relief Therapeutics Holding’s CHF 5 Million Private Placement
Innov Ad N.V.’s Acquisition of Herbonis AG
VISCHER advised the selling Herbonis shareholders in this transaction. Innovad, a leading provider of animal nutrition and health solutions, is pleased to announce that it is...
Hangzhou GreatStar Industrial Co., Ltd.’s Listing on the SIX Swiss Exchange
Clifford Chance, Niederer Kraft Frey, Vischer and T&C Law Firm advised Hangzhou GreatStar Industrial Co., Ltd. on the deal. Allen & Overy advised the sole global...
e-hoi AG’s Acquisition of Cruise Center AG
VISCHER advised e-hoi AG on the deal. Cruise Center AG, a Swiss company that has been selling cruises for over twenty years, was acquired by the...
HomeToGo’s €40 Million Acquisition of e-domizil
Flick Gocke Schaumburg and Vogel Heerma Waitz advised HomeToGo on the deal. Wendelstein Vischer, KNPZ Rechtsanwälte and RGT Consultants advised e-domizil. HomeToGo announced the acquisition of e-domizil...
Mainova’s Acquisition of a Majority Stake in Mobiheat
McDermott Will & Emery and Vischer advised Mainova AG on the deal. Mainova executed the acquisition of a majority stake in energy service provider mobiheat GmbH. The...
Relief Therapeutics’ CHF 15 Million Shares Private Placement
Pestalozzi advised H.C. Wainwright LLC on the deal, while VISCHER advised Relief Therapeutics. RELIEF THERAPEUTICS Holding AG. a biopharmaceutical company seeking to provide patients therapeutic relief from...
Relief Therapeutics’ Acquisition of Applied Pharma Research S.A.
VISCHER advises Relief Therapeutics regarding all legal aspects of this transaction. RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced...
Relief Therapeutics’ Acquisition of Applied Pharma Research S.A.
VISCHER advises Relief Therapeutics regarding all legal aspects of this transaction. RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced...
Unsere Champions’ Entry Into Swiss Market
Vischer and McDermott Will & Emery advised Unsere Champions on the deal. Unsere Champions, a successful operator of day nurseries and kindergartens in southern Germany, acquired,...
Relief Therapeutics Holding AG’s CHF 10 Million Shares Private Placement
Pestalozzi advised H.C. Wainwright LLC, as sole placement agent for the offering, while VISCHER advised Relief regarding the Swiss legal aspects of this transaction. RELIEF THERAPEUTICS...